Cargando…
AORTIC VALVE ENDOCARDITIS AS A COMPLICATION OF TOCILIZUMAB TREATMENT IN COVID 19 PATIENT
Autores principales: | Ashraf, Shoaib, Saad, Muhammad, Ali, Nisha, Kamalakkannan, Gayathri, Singh, Amandeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Cardiology Foundation. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091380/ https://www.ncbi.nlm.nih.gov/pubmed/34140102 http://dx.doi.org/10.1016/S0735-1097(21)04357-6 |
Ejemplares similares
-
NATIVE VALVE ENDOCARDITIS: A COMPLICATION OF TOCILIZUMAB TREATMENT IN COVID-19 PNEUMONIA
por: You, Joseph, et al.
Publicado: (2022) -
UNICUSPID AORTIC VALVE CONCOMITANT WITH INFECTIVE ENDOCARDITIS AND SEVERE AORTIC REGURGITATION IN A PATIENT WITH COVID-19
por: Joshi, Gunjan S., et al.
Publicado: (2021) -
TOCILIZUMAB- A TREATMENT OPTION FOR TORSADES DE POINTES IN COVID-19 PATIENTS
por: Anwaar, Muhammad Faraz, et al.
Publicado: (2023) -
COVID-19 INFECTION PREDISPOSING ENDOCARDITIS COMPLICATED BY THE CHALLENGES OF PATIENT CARE IN A PANDEMIC
por: Lowell, Andrew, et al.
Publicado: (2021) -
COVID-19 INDUCED CARDIOMYOPATHY SUCCESSFULLY TREATED WITH TOCILIZUMAB
por: Fakhra, Sadaf, et al.
Publicado: (2022)